Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

1) $(7,461) $(731,950)

Amortization of

intangibles $(201,105) $(201,105)

Purchase of

in-process

research and

development $(106,350) $(106,350)

Equity in income

(loss) of equity

method

investments $(19,150) $(830) $3,830 $7,398

Minority interest $3,831 $3,932

Gains (losses) on

investments in

equity securities $13,067

Other $(7,118)

Investment income $70,196

Interest Expense $(12,147)

Summary:

Income (loss)

before income

taxes $(125,500) $(201,935) $(189,950) $- $735,674

(Provision for)

benefit from

income taxes 15,781 72,449 58,148 - (255,481)

Net income

(loss) $(109,719) $(129,486) $(131,802) $- $480,193

Net income

(loss) per share:

Basic $(0.41) $(0.49) $(0.50) $- $1.82

Diluted (1) $(0.39) $(0.46) $(0.47) $- $1.74

Weighted average

shares outstanding:

Basic 263,895

Diluted (1) 280,767

(1) Non-GAAP basic and diluted earnings per share reflects the sum of the

quarterly Non-GAAP diluted earnings per share activity for Q1-Q4 2007.

(2) GAAP As-Reported diluted earnings per share and diluted weighted

average shares outstanding reflect the adoption of EITF 04-8. In

accordance with the provisions of EIT
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... As testosterone therapy lawsuit filings ... and blood clots from using testosterone products such as ... shows that the male hormone testosterone may increase the ... published in the Proceedings of the National Academy of ... group of male rats with naturally occurring colon cancer. ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly ... announced its bamboo flooring promotion for the coming ... certified suppliers, and offers the best bamboo products ... current promotion, all customers can enjoy a special ... they know BambooIndustry.com from press releases. , The ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 DePuy ... a metal-on-metal version of the artificial hip system ... state and federal courts, Bernstein Liebhard LLP reports. ... Bergen County Superior Court on December 2nd, counsel ... begin deposition of plaintiffs on November 19, 2014, ...
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer and retailer, ... The company has recently updated its official blog with ... season, Angeldress Blog has recommended some new ... prides itself in offering a huge selection of elegant ... company’s outfits are very carefully selected based on the ...
(Date:12/20/2014)... Aliso Viejo, California (PRWEB) December 20, 2014 ... have announced the release of a new plugin for ... Pixel Film Studios. , “TranSlice Volume 5 allows users ... literally hand draw it.” Said Christina Austin, CEO of ... to add level of professionalism while maintaining an easy ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... California, San Diego (UCSD) School of Medicine, liver cancer ... death and renewal – liver cell proliferation. ... in advance of publication in the journal Proceedings of ... JNK1-mediated cell death and compensatory proliferation. The findings by ...
... reported that there appears to be three variations of ... on humans upon their susceptibility towards tuberculosis// . Researchers ... to why some patients infected with the Mycobacterium tuberculosis ... not affected. The findings was published in the online ...
... that has twice the amount of oleic acid found in ... //is being tested by researchers at the Iowa State University ... oil can go where no unhydrogenated soybean oil has gone ... sauces and non-dairy creamers) that require more stability than previous ...
... Reddy's Laboratories today announced that it has launched the authorized ... June 19. // ,The company has also launched ... mg, 10 mg, 20 mg, 40 mg and 80 mg ... year, the company entered into separate agreements with Merck that ...
... habits can help lessen the intensity of migraines, says ... neurology //at the University of North Carolina Medical School, ... who improved their sleep habits had reduced headache frequencies. ... headache frequency by 29 percent and headache intensity by ...
... fund raisers are taking part in the moon walk which will ... walk along with the famous TV star Lorraine Kelly. ... one million pounds for breast cancer and the Maggie’s Centre. They ... the day of the event. ,Hence the name Moon ...
Cached Medicine News:Health News:Repeated Liver Cell Proliferation, a Cause for Liver Cancer 2Health News:Susceptibility Of TB In Humans Might Be Due To Three Human Gene Variants 2Health News:New Variety Of Soybean Oil 2
(Date:12/19/2014)... , Dec. 19, 2014   Hospira, Inc. ... provider of injectable drugs and infusion technologies, today announced ... 33rd Annual Healthcare Conference on Wednesday, Jan. 14, 2015, ... is scheduled to begin at 10:30 a.m. Pacific time ... to all interested parties through a live audiocast accessible ...
(Date:12/19/2014)... Colo. , Dec. 19, 2014  Monarch America ... Cannabis Kinetics Corp.) is pleased to provide this review ... continued growth in 2015. "Over this past ... goals and I am extremely proud to say that ... position today than it has ever been," stated ...
(Date:12/19/2014)... -- Somewhere between dropping five pounds and cooking more ... Audicus , a next-generation hearing aids company, will help ... Hearing loss is the third most common chronic ... often unaddressed. Forty-eight million Americans have hearing loss, but ... due to price. Hearing aids traditionally cost $7,000 per ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Audicus Will Help People Resolve to Hear Better in 2015 2
... 2010 Stereotaxis, Inc. (Nasdaq: STXS ) announced ... to offer its common stock in a registered public offering ... Act of 1933. Stereotaxis also intends to grant the underwriters ... common stock to cover over-allotments, if any. Stereotaxis ...
... 10, 2010 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17, ...   Interested parties may access a live webcast ... It is recommended that listeners log on 15 ...
Cached Medicine Technology:Stereotaxis Announces Public Offering of Common Stock 2Stereotaxis Announces Public Offering of Common Stock 3Stereotaxis Announces Public Offering of Common Stock 4Onyx Pharmaceuticals to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2
... 30 years, Digisonics has set the ... the first review station, the only ... the best multi-modality reporting., ,DigiView cardiology ... review workstations, professional reporting choices, an ...
... Rapid measurement of colloid osmotic (oncotic) ... onset in clinical situations. Uses a ... chambers to simulate the role of ... establishment of osmotic pressure responsible for ...
Quantitative determination of cortisol levels in serum and urine. Cross-reactivity with dexamethasone: 0.2% (suppression test).Time to first result: 30 minutes....
... IMMULITE 2000 assays are ... the IMMULITE 2000, a ... immunoassay analyzer. IMMULITE 2000 ... centralization, and a rapidly ...
Medicine Products: